CLINICAL_TRIALS
trial_result
· 2025-07-16
Clinical Trial Update: Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma [Phase 1]
Summary
Phase 1 trial evaluating the safety and tolerability of a timolol-releasing intraocular implant in adults with primary open-angle glaucoma; the study was termin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EyeD Pharma | Conditions: Primary Open-angle Glaucoma | Phase 1 | Status: TERMINATED